KR20240144140A - Kif18a 억제제의 합성 - Google Patents

Kif18a 억제제의 합성 Download PDF

Info

Publication number
KR20240144140A
KR20240144140A KR1020247024721A KR20247024721A KR20240144140A KR 20240144140 A KR20240144140 A KR 20240144140A KR 1020247024721 A KR1020247024721 A KR 1020247024721A KR 20247024721 A KR20247024721 A KR 20247024721A KR 20240144140 A KR20240144140 A KR 20240144140A
Authority
KR
South Korea
Prior art keywords
compound
solvent
alkyl
acid
benzyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020247024721A
Other languages
English (en)
Korean (ko)
Inventor
세바스쳔 카일
다니엘 게라드 그린
마이클 토마스 코르벳
캐롤린 웨이
Original Assignee
암젠 인코포레이티드
암젠 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 암젠 인코포레이티드, 암젠 인코포레이티드 filed Critical 암젠 인코포레이티드
Publication of KR20240144140A publication Critical patent/KR20240144140A/ko
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C313/00—Sulfinic acids; Sulfenic acids; Halides, esters or anhydrides thereof; Amides of sulfinic or sulfenic acids, i.e. compounds having singly-bound oxygen atoms of sulfinic or sulfenic groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C313/02—Sulfinic acids; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/20—Spiro-condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
KR1020247024721A 2022-01-26 2023-01-26 Kif18a 억제제의 합성 Pending KR20240144140A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263303470P 2022-01-26 2022-01-26
US63/303,470 2022-01-26
PCT/US2023/011636 WO2023146973A1 (en) 2022-01-26 2023-01-26 Synthesis of a kif18a inhibitor

Publications (1)

Publication Number Publication Date
KR20240144140A true KR20240144140A (ko) 2024-10-02

Family

ID=85328813

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020247024721A Pending KR20240144140A (ko) 2022-01-26 2023-01-26 Kif18a 억제제의 합성

Country Status (12)

Country Link
US (1) US20250129050A1 (cg-RX-API-DMAC10.html)
EP (1) EP4469437A1 (cg-RX-API-DMAC10.html)
JP (1) JP2025505892A (cg-RX-API-DMAC10.html)
KR (1) KR20240144140A (cg-RX-API-DMAC10.html)
CN (1) CN118922406A (cg-RX-API-DMAC10.html)
AR (1) AR128353A1 (cg-RX-API-DMAC10.html)
AU (1) AU2023211589A1 (cg-RX-API-DMAC10.html)
CA (1) CA3248925A1 (cg-RX-API-DMAC10.html)
IL (1) IL314221A (cg-RX-API-DMAC10.html)
MX (1) MX2024009163A (cg-RX-API-DMAC10.html)
TW (1) TW202342451A (cg-RX-API-DMAC10.html)
WO (1) WO2023146973A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL283639B2 (en) 2018-12-20 2024-06-01 Amgen Inc Kif18a inhibitors
CR20250087A (es) 2022-08-18 2025-07-11 Accent Therapeutics Inc Inhibidores de kif18a y usos de estos
CN115925589A (zh) * 2022-12-26 2023-04-07 诚达药业股份有限公司 一种脂肪族亚磺酸钙盐及其制备方法
CN121693499A (zh) * 2023-08-16 2026-03-17 上海湃隆生物科技有限公司 驱动蛋白kif18a抑制剂及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL283639B2 (en) * 2018-12-20 2024-06-01 Amgen Inc Kif18a inhibitors
JP2023521802A (ja) * 2020-04-14 2023-05-25 アムジエン・インコーポレーテツド 新生物疾患の処置のためのkif18a阻害剤

Also Published As

Publication number Publication date
CA3248925A1 (en) 2023-08-03
AR128353A1 (es) 2024-04-24
WO2023146973A1 (en) 2023-08-03
AU2023211589A1 (en) 2024-07-25
US20250129050A1 (en) 2025-04-24
TW202342451A (zh) 2023-11-01
IL314221A (en) 2024-09-01
EP4469437A1 (en) 2024-12-04
JP2025505892A (ja) 2025-03-03
MX2024009163A (es) 2024-08-09
CN118922406A (zh) 2024-11-08

Similar Documents

Publication Publication Date Title
US20250129050A1 (en) Synthesis of a kif18a inhibitor
TWI475992B (zh) 製備4-{4-[({[4-氯-3-(三氯甲基)-苯基]胺基}羰基)胺基]-3-氟苯氧基}-n-甲基吡啶-2-甲醯胺、其鹽及單水合物之方法
JP7157752B2 (ja) Ag-10、その中間体及びその塩の調製方法
CN102143964A (zh) 制备腺嘌呤化合物的方法
KR20160072127A (ko) Pde4 억제제의 제조 방법
AU2020267299A1 (en) Methods of making protein deacetylase inhibitors
TW201738236A (zh) 一種製備酪胺酸激酶抑制劑及其衍生物的方法
BRPI0715831A2 (pt) processo para produÇço da 1-(3,4-diclorobenzil)-5-octilbiguanida ou um sal da mesma
EP4063351A1 (en) Preparation method of quinoline derivative compounds
EP3348554B1 (en) Method for producing triazole compound
RU2466983C2 (ru) Способ синтеза сульфонилгалогенидов и сульфонамидов из солей сульфоновых кислот
EA052216B1 (ru) Синтез ингибитора kif18a
CN111100111B (zh) 一种制备苯并噻吩衍生物的方法
AU2010299484A1 (en) Polymorphs of sorafenib acid addition salts
IL93393A (en) Process for the preparation of omicron-carboxypyridyl and omicron-carboxyquinolyl- imidazolinones
KR20160056230A (ko) 블로난세린의 제조방법 및 그를 위한 중간체
US10011567B1 (en) Method for the synthesis of acrylate derivatives
KR101278359B1 (ko) Npyy5 수용체 길항 작용을 갖는 화합물의 제조 방법 및 유용한 결정
JPH0350748B2 (cg-RX-API-DMAC10.html)
KR20140027921A (ko) 디(아릴아미노)아릴 화합물의 제조 방법 및 그 합성 중간체
CN110914250B (zh) 用于合成非罗考昔的新工艺
IT202300023508A1 (it) Processo per la preparazione della forma polimorfa iii di tapinarof
DK163660B (da) Fremgangsmaade til fremstilling af benzylalkoholderivater eller farmaceutisk acceptable syreadditionssalte deraf
KR20060070566A (ko) 디페닐 에테르 화합물의 신규 제조방법
EA050035B1 (ru) Способы получения ag-10, его промежуточных соединений и их солей

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E13 Pre-grant limitation requested

Free format text: ST27 STATUS EVENT CODE: A-2-3-E10-E13-LIM-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000